Histologic Evaluation of Healing Following Tooth Extraction With Ridge Preservation Using NuOss XC and NuOss Particulate

July 5, 2013 updated by: University of Oklahoma
This study histologically evaluates sites grafted with NuOss XC using ridge preservation techniques prior to placement of dental implants. Sites grafted with NuOss XC (bovine bone mineral with self-expanding collagen) will be compared to sites grafted with NuOss particulate (bovine bone mineral).

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Patients presenting to the University of Oklahoma College of Dentistry Graduate Periodontics Clinic who are treatment planned for tooth extraction and placement of dental implant(s) will be interviewed for possible participation in the study. Forty extraction sites will be included in this study to provide statistical significance.

The ridge preservation sites, using either NuOss XC or NuOss particulate, will be selected randomly. The first site will be selected using the flip of a coin. Thereafter, every other site will be grafted using NuOs XC. The ridge preservation procedure will involve tooth extraction with as little trauma as possible to preserve all four bony socket walls, curettage of the socket to remove all periodontal ligament fibers and granulation tissue, placement of the graft material into the socket and coverings the graft material with long-lasting collagen membrane. Facial and lingual mucoperiosteal flaps will be elevated to facilitate securing of the membrane with long-lasting absorbable sutures. Patient will be given prescriptions for analgesics and antibiotics as necessary.

Study Type

Observational

Enrollment (Actual)

22

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Oklahoma
      • Oklahoma City, Oklahoma, United States, 73126
        • University of Oklahoma College of Dentistry

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 64 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Periodontal Clinic Population at the University of Oklahoma College of Dentistry

Description

INCLUSION CRITERIA:

  • may be either male or female
  • must be between 18 and 64 years old
  • must be of sufficiently good health to undergo routine dental treatment, including the surgical procedures associated with tooth extraction and placement of NuOss XC or NuOss particulate
  • must agree to remain in study for 6 months after ridge preservation (grafting)
  • must be able to physically, emotionally, and financially undergo the surgical and restorative (implant replacement) procedures planned.
  • must not have medical conditions that preclude the removal of indicated teeth and placement of NuOss XC or NuOss particulate
  • must have at least one single-rooted tooth to be extracted
  • must consent to tooth extractions, socket augmentation and implant placement
  • Patients with or without dental insurance

Exclusion Criteria:

  • have any requirements for antibiotic premedication for heart murmurs, artificial joints, or any other condition
  • have a history of significant heart, stomach, liver, kidney, blood, immune system or other organ impairment or systemic disease that would prevent their undergoing the proposed treatment
  • smoke ≥ 10 cigarettes per day or use other tobacco products
  • have a religious or philosophical aversion to having processed bovine bone or collagen used in their mouth
  • have taken any investigational drugs anytime in the previous month
  • have dental conditions likely to require treatment, necessitating exit from the study such as deep caries, abscesses, or moderate-severe periodontal disease(s).
  • have sockets that do not have four bony walls intact.
  • cannot comply with treatment and follow-up visits for 6 months
  • have had significant radiation exposure (occupational, therapeutic, diagnostic).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
NuOss XC
Bone grafting material used in this group will be NuOss XC.
NuOss XC is a bone grafting material that will be placed in extraction socket site.
NuOss Particulate
Bone grafting material used in this group will be NuOss Particulate.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Histological analysis: All sections removed from the osteotomy (hole where implant will be placed) at time of implant placement to be evaluated by a single evaluator, using a semi-quantitative scoring system
Time Frame: 12-18 months

Histological processing: Specimens to be trimmed and embedded in methyl methacrylate (MMA). One hematoxylin and eosin (H&E) stained section, and one Goldner's trichrome-stained section to be taken from each block in a longitudinal plane through the approximate center of each defect.

Goldner's trichrome-stained slides to be scored for the presence of bone and bone marrow as a percent of the total defect area.

H&E-stained slides to be used to evaluate residual collagen and residual bone mineral as a percent of the total defect area.

12-18 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Robert Carson, DMD, MS, University of Oklahoma College of Dentistry

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2011

Primary Completion (ACTUAL)

January 1, 2013

Study Completion (ACTUAL)

May 1, 2013

Study Registration Dates

First Submitted

July 1, 2011

First Submitted That Met QC Criteria

July 8, 2011

First Posted (ESTIMATE)

July 12, 2011

Study Record Updates

Last Update Posted (ESTIMATE)

July 8, 2013

Last Update Submitted That Met QC Criteria

July 5, 2013

Last Verified

July 1, 2013

More Information

Terms related to this study

Other Study ID Numbers

  • Nuoss-15852

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Oral Ridge Preservation

Clinical Trials on NuOss XC

3
Subscribe